Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

NCT01379703 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01379703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01379703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
February 29, 2004
Completion date
February 28, 2010
Enrollment
2,288 (actual)
Sites
103

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 patients